AMICUS THERAPEUTICS, INC. — Director's Dealing 2012

Mar 9, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2012-03-07

Reporting Person: PERRY MARK W (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-07	Common Stock	P	214846	$5.70	Acquired	1066029	Indirect
2012-03-07	Common Stock	P	925154	$5.70	Acquired	4584311	Indirect

Footnotes

F1: On March 7, 2012, New Enterprise Associates 9, Limited Partnership ("NEA 9"), purchased 214,846 shares of Common Stock in the Issuer's registered underwritten public offering at the price to the public of $5.70 per share.

F2: The Reporting Person is a general partner of NEA Partners 9, Limited Partnership, the sole general partner of NEA 9, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 9 shares in which the Reporting Person has no pecuniary interest.

F3: On March 7, 2012, New Enterprise Associates 11, Limited Partnership ("NEA 11"), purchased 925,154 shares of Common Stock in the Issuer's registered underwritten public offering at the price to the public of $5.70 per share.

F4: The Reporting Person is an individual manager of NEA 11 GP, LLC, the sole general partner of NEA Partners 11, Limited Partnership ("NEA Partners 11"). NEA Partners 11 is the sole general partner of NEA 11, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 11 securities in which the Reporting Person has no pecuniary interest.